Research Paper Volume 8, Issue 2 pp 345—365
p63 expression confers significantly better survival outcomes in high-risk diffuse large B-cell lymphoma and demonstrates p53-like and p53-independent tumor suppressor function
Figure 4. Relationship between TP63/p63 and TP53/p53 expression in DLBCL. (A) Comparison of wild-type (WT) or mutated (MUT) p53 protein expression between p63+ and p63− patients with DLBCL or GCB/ABC subtypes of DLBCL. (B) Comparison of TP53 mRNA expression between p63+ and p63− patients with WT-TP53 or MUT-TP53 and GCB/ABC DLBCL. (C) Comparison of p63 protein expression between WT-TP53 and MUT-TP53 DLBCL, and between p53+ and p53− patients with DLBCL or GCB/ABC subtypes of DLBCL. (D) Comparison of TP63 mRNA expression between WT-TP53 and MUT-TP53 DLBCL, and between p53+ and p53− patients with DLBCL or GCB/ABC subtypes of DLBCL.